Oral Squamous Cell Carcinoma
Symptoms, Doctors, Treatments, Advances & More

Oral Squamous Cell Carcinoma Overview

Save information for later
Sign Up

Learn About Oral Squamous Cell Carcinoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Oral Squamous Cell Carcinoma Local Doctors?
Distinguished in Oral Squamous Cell Carcinoma
Otolaryngology
Distinguished in Oral Squamous Cell Carcinoma
Otolaryngology

Ear Nose And Throat Associates, PC

2340 Knob Creek Rd, Suite 704, 
Johnson City, TN 
Languages Spoken:
English

Timothy Zajonc is an Otolaryngologist practicing medicine in Johnson City, Tennessee. Dr. Zajonc is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Nasal Septal Hematoma, Low Nasal Bridge, Perichondritis, and Myringotomy. Dr. Zajonc is board certified in American Board Of Otolaryngology.

Advanced in Oral Squamous Cell Carcinoma
Hematology | Oncology
Advanced in Oral Squamous Cell Carcinoma
Hematology | Oncology

Cancer Centers Of Colorado - St. Mary's Regional Hospital (Med Onc)

750 Wellington Avenue, 
Grand Junction, CO 
Experience:
14+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Dr. Kyle Work joined the Cancer Centers of Colorado at St. Mary?s Medical Center oncology team in 2018. He is a hematologist-oncologist. Dr. Work treats all types of cancers with a special interest in head and neck cancer, lung cancer and genitourinary cancers.Dr. Work is originally from Tulsa, Oklahoma where he graduated from the University of Tulsa with a degree in biology, and earned his medical degree at Oklahoma State University. He then moved to Kansas City where he completed his internal medicine residency and hematology / oncology fellowship at the University of Kansas Health System. During his hematology and oncology fellowship, he served as chief fellow for two years.Dr. Work is an investigator involved in clinical research trials in the area of hematology and medical oncology. His clinical research focus includes head and neck cancers, brain and lung cancers. When he is not working, he enjoys mountain biking, camping, and hiking with his wife and golden retrievers. Dr. Work is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Work is board certified in American Board Of Internal Medicine. Dr. Work is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Oral Squamous Cell Carcinoma
Elite in Oral Squamous Cell Carcinoma
Toon, JP 

Koh-ichi Nakashiro practices practicing medicine in Toon, Japan. Nakashiro is rated as an Elite expert by MediFind in the treatment of Oral Squamous Cell Carcinoma. They are also highly rated in 1 other condition, according to our data. Their clinical expertise encompasses Oral Squamous Cell Carcinoma, Candida Infection of the Skin, Head and Neck Squamous Cell Carcinoma (HNSCC), and Adenoid Cystic Carcinoma.

What are the latest Oral Squamous Cell Carcinoma Clinical Trials?
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma: A Multicenter, Open-label, Randomized, Phase III Clinical Study

Summary: This is a multicenter, open-label, randomized phase III clinical trial evaluating perioperative treatment with sintilimab combined with chemotherapy in patients with locally advanced oral squamous cell carcinoma. Despite standard treatment with surgery followed by postoperative radiotherapy or chemoradiotherapy, patients with locally advanced oral squamous cell carcinoma remain at high risk of rec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy

Summary: Investigating the Relationship Between Oral Microbiome Alterations and Tumor Markers in Locally Advanced Oral Squamous Cell Carcinoma (LA-OSCC) After Neoadjuvant Chemoimmunotherapy: Implications for Therapeutic Efficacy, Chemoresistance, and Prognostic Assessment